Atopic Dermatitis

Atopic Dermatitis – Friday Pop Quiz – 4/1/2022
152731527315273 A father brings in his child who has a history of atopic dermatitis.  He reports a one-week history of blisters on the extremities and states this looks different than his usual eczema. The child is well appearing and happily cooperative with your exam.  What is the next step in management? A. Scabies prep B. Wound culture C. Tzanck smear D. Potassium hydroxide prep E. Punch b …
JDD Issue Highlights | March 2022
151531515315153The March 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from acne and psoriasis to Platelet Rich Plasma (PRP) for scarring alopecia and racial differences and their impact on treatment for hidradenitis suppurativa, we share this month’s issue highlights straight from the JDD Editor’s de …
What’s New in Atopic Dermatitis
149731497314973atopic dermatitisNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Adam Friedman (Professor and Chair of Dermatology who serves as Associate Residency Program Director, Director of Translational Research, and Director of the Supportive Oncodermatology Program in the GW Department of Dermatology) about the latest in Atopic Dermatitis (AD). Watch as he discu …
atopic dermatitis
Chromate-Induced Allergic Contact Dermatitis Treated With Dupilumab
149451494514945Chromate-Induced Allergic Contact Dermatitis Treated With DupilumabChromate causes persistent, difficult to treat irritant and allergic contact dermatitis in cement-handling occupational workers. When therapeutics such as topical corticosteroids, topical calcineurin inhibitors, phototherapy and immune-modulating treatments like methotrexate fail, many patients are advised that avoidance may be the only remaining option – an option that may be particularly chall …
Chromate-Induced Allergic Contact Dermatitis Treated With Dupilumab
JDD Issue Highlights | February 2022
148041480414804psoriasisThe February 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from psoriasis and actinic keratoses to artificial intelligence in dermatology and disparities in telemedicine satisfaction, we share this month’s issue highlights straight from the JDD Editor’s desk: Early Response is Associ …
psoriasis